Affimed N.V. (AFMD) Financials

AFMD Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 44.5 million 25.4 million
June 30, 2024 57.1 million 26.3 million
March 31, 2024 76.1 million 32.3 million
Dec. 31, 2023 107.4 million 43.5 million

AFMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -12.4 million 736112
June 30, 2024 -17.7 million 733202
March 31, 2024 -25.7 million 851527
Dec. 31, 2023 -28.7 million 1.6 million

AFMD Net Income

No data available :(

AFMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 27.8 million 6.7 million 5.4 million
June 30, 2024 37.9 million 8.2 million 5.5 million
March 31, 2024 53.3 million 10.0 million 5.7 million
Dec. 31, 2023 80.6 million 14.3 million 8.0 million

AFMD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 17.9 million
June 30, 2024 16.4 million
March 31, 2024 16.3 million
Dec. 31, 2023 16.5 million

AFMD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 5568 11.3 million 4.8 million -
June 30, 2024 20396 12.6 million 4.3 million -
March 31, 2024 1079 16.6 million 4.8 million -
Dec. 31, 2023 562677 20.6 million 6.8 million -

AFMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 172613 -
June 30, 2024 165319 -
March 31, 2024 167283 -
Dec. 31, 2023 456553 -

AFMD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AFMD

Price: $0.18

52 week price:
0.02
8.95

Earnings Per Share: -5.09 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 1.5 million

Ebitda: -9.1 million

Market Capitalization: 3.0 million

Links: